CT83

CT83
識別號
别名	CT83；, CXorf61, KK-LC-1, KKLC1, cancer/testis antigen 83
外部ID	OMIM：300625 HomoloGene：128483 GeneCards：CT83
基因位置（人类）
染色体	X染色體
终止	116,462,976 bp
直系同源
	203413
	无数据
	ENSG00000204019
	无数据
	Q5H943
	无数据
	NM_001017978
	无数据
	NP_001017978
	无数据
	維基數據
檢視/編輯人類

CT83全称为肿瘤-睾丸抗原83（英語：Cancer/testis antigen 83）是人类基因组中X染色体上 CT83 编码的蛋白质^[3]，属于CT抗原之一，可在非小细胞肺癌（英语：Non-small-cell lung cancer）（NSCLC）等癌症细胞上表达^[4]^[5]。

参考文献

^ ^1.0 ^1.1 ^1.2 GRCh38: Ensembl release 89: ENSG00000204019 - Ensembl, May 2017
^ Human PubMed Reference:. National Center for Biotechnology Information, U.S. National Library of Medicine.
^ Entrez Gene: Cancer/testis antigen 83. [2016-02-07]. （原始内容存档于2023-07-04）.
^ Baba, T; Shiota, H; Kuroda, K; Shigematsu, Y; Ichiki, Y; Uramoto, H; Hanagiri, T; Tanaka, F. Cancer/testis antigen expression as a predictor for epidermal growth factor receptor mutation and prognosis in lung adenocarcinoma.. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2013-04, 43 (4): 759–64. PMID 22826471. doi:10.1093/ejcts/ezs426.
^ Fukuyama, T; Hanagiri, T; Takenoyama, M; Ichiki, Y; Mizukami, M; So, T; Sugaya, M; So, T; Sugio, K; Yasumoto, K. Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.. Cancer research. 2006-05-01, 66 (9): 4922–8. PMID 16651449. doi:10.1158/0008-5472.CAN-05-3840.